Market Overview:
The global molecular beacon probe market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for nucleic acid detection and analysis, quantitative detection of heavy metal toxic substances, research on tumor markers, research on toxic residual antibiotics and other substances, and other applications. North America is expected to dominate the global molecular beacon probe market during the forecast period owing to technological advancements in this region.
Product Definition:
A molecular beacon probe is a type of nucleic acid probe that consists of a fluorophore and a quencher. The fluorescence of the fluorophore is quenched by the quencher when the two are in close proximity. However, when the probe separates from its target sequence, the fluorescence is restored. This allows for detection of specific sequences in a sample.
Tag Molecular Beacon:
Tag Molecular Beacon, also known as TMB or tag-MWR is a new technology that allows specific and sensitive detection of biomolecules such as DNA, RNA and proteins. It works by binding to the target molecule which can be either an entire gene or a single protein sequence. The technique was first developed for the study of molecular beacons (MWRs) in 1999 by researchers at Tag Diagnostics who were awarded with patent rights in 2001.
Label-free Molecular Beacon:
The Label-free molecular beacon is a new technology that enables the detection of cell type and biomarker information in single cells. It does not use fluorescent or radioactive labels, but rather utilizes the naturally occurring phosphorescence of proteins to detect and identify cellular properties. The major advantage of this technique is that it can be used for any biological sample, such as blood, tissue, urine etc., without contamination due to fluorescent or radioactive labels.
Application Insights:
The research on tumor markers segment dominated the global molecular beacon probe market in terms of revenue share in 2017. Tumor biomarkers are molecular probes that are used for the detection, estimation, and monitoring of cancer at its early stages. The rising prevalence of chronic diseases such as cancer worldwide is expected to be a major factor driving the demand for these products over the forecast period.
Nucleic acid detection and analysis was estimated as the second-largest segment owing to increasing applications in various fields such as forensics, clinical diagnostics, drug discovery & development (R&D), etc.
Regional Analysis:
North America dominated the global molecular beacon probe market in 2017. This is due to the presence of a large number of research organizations and universities involved in cancer research, which has resulted in an increased demand for MCPs. The region will retain its dominance throughout the forecast period owing to continuous efforts by major companies engaged in this business to develop novel molecular beacons with improved characteristics such as low cost, high specific activity, long shelf life and small size.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing government funding for cancer research along with rising awareness about oncology diseases among patients from China and India. These countries contribute significantly towards revenue generation through licensing fees and product sales while also generating significant demand through their rapidly growing economies that require rapid diagnostic solutions for patient care coupled with improving healthcare infrastructure at both domestic level as well as international levels.
Growth Factors:
- Increasing demand for molecular beacon probes in the field of diagnostics and therapeutics
- Rising prevalence of target diseases that can be effectively diagnosed and treated using molecular beacon probes
- Growing number of R&D initiatives focused on the development of novel molecular beacon probe-based diagnostic and therapeutic approaches
- Proliferation of personalized medicine approaches that rely on accurate detection and characterization of disease-related biomarkers
- Technological advancements that are enabling more sensitive, specific, and rapid detection of target molecules using molecular beacon probes
Scope Of The Report
Report Attributes
Report Details
Report Title
Molecular Beacon Probe Market Research Report
By Type
Tag Molecular Beacon, Label-free Molecular Beacon
By Application
Nucleic Acid Detection and Analysis, Quantitative Detection of Heavy Metal Toxic Substances, Research On Tumor Markers, Research On Toxic Residual Antibiotics and Other Substances, Other
By Companies
Biocat, Bionano Genome, ThermoFisher, Biolegio, QIAGEN, Seattle Genetics, Karuna Therapeutics, Bristol-Myers Squibb, Pfizer, Oncolytics Biotech, Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Molecular Beacon Probe Market Report Segments:
The global Molecular Beacon Probe market is segmented on the basis of:
Types
Tag Molecular Beacon, Label-free Molecular Beacon
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Nucleic Acid Detection and Analysis, Quantitative Detection of Heavy Metal Toxic Substances, Research On Tumor Markers, Research On Toxic Residual Antibiotics and Other Substances, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biocat
- Bionano Genome
- ThermoFisher
- Biolegio
- QIAGEN
- Seattle Genetics
- Karuna Therapeutics
- Bristol-Myers Squibb
- Pfizer
- Oncolytics Biotech
- Roche
Highlights of The Molecular Beacon Probe Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tag Molecular Beacon
- Label-free Molecular Beacon
- By Application:
- Nucleic Acid Detection and Analysis
- Quantitative Detection of Heavy Metal Toxic Substances
- Research On Tumor Markers
- Research On Toxic Residual Antibiotics and Other Substances
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molecular Beacon Probe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Molecular Beacon Probe (MBP) is a type of sensor that uses the principles of quantum mechanics to detect and identify molecules or particles. The probe emits a short-wavelength light signal that can be detected by an optical detector. When the light signal is received, it can be used to identify the specific molecule or particle that was detected.
Some of the major companies in the molecular beacon probe market are Biocat, Bionano Genome, ThermoFisher, Biolegio, QIAGEN, Seattle Genetics, Karuna Therapeutics, Bristol-Myers Squibb, Pfizer, Oncolytics Biotech, Roche.
The molecular beacon probe market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Molecular Beacon Probe Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Molecular Beacon Probe Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Molecular Beacon Probe Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Molecular Beacon Probe Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Molecular Beacon Probe Market Size & Forecast, 2018-2028
4.5.1 Molecular Beacon Probe Market Size and Y-o-Y Growth
4.5.2 Molecular Beacon Probe Market Absolute $ Opportunity
Chapter 5 Global Molecular Beacon Probe Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Molecular Beacon Probe Market Size Forecast by Type
5.2.1 Tag Molecular Beacon
5.2.2 Label-free Molecular Beacon
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Molecular Beacon Probe Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Molecular Beacon Probe Market Size Forecast by Applications
6.2.1 Nucleic Acid Detection and Analysis
6.2.2 Quantitative Detection of Heavy Metal Toxic Substances
6.2.3 Research On Tumor Markers
6.2.4 Research On Toxic Residual Antibiotics and Other Substances
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Molecular Beacon Probe Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Molecular Beacon Probe Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Molecular Beacon Probe Analysis and Forecast
9.1 Introduction
9.2 North America Molecular Beacon Probe Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Molecular Beacon Probe Market Size Forecast by Type
9.6.1 Tag Molecular Beacon
9.6.2 Label-free Molecular Beacon
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Molecular Beacon Probe Market Size Forecast by Applications
9.10.1 Nucleic Acid Detection and Analysis
9.10.2 Quantitative Detection of Heavy Metal Toxic Substances
9.10.3 Research On Tumor Markers
9.10.4 Research On Toxic Residual Antibiotics and Other Substances
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Molecular Beacon Probe Analysis and Forecast
10.1 Introduction
10.2 Europe Molecular Beacon Probe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Molecular Beacon Probe Market Size Forecast by Type
10.6.1 Tag Molecular Beacon
10.6.2 Label-free Molecular Beacon
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Molecular Beacon Probe Market Size Forecast by Applications
10.10.1 Nucleic Acid Detection and Analysis
10.10.2 Quantitative Detection of Heavy Metal Toxic Substances
10.10.3 Research On Tumor Markers
10.10.4 Research On Toxic Residual Antibiotics and Other Substances
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Molecular Beacon Probe Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Molecular Beacon Probe Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Molecular Beacon Probe Market Size Forecast by Type
11.6.1 Tag Molecular Beacon
11.6.2 Label-free Molecular Beacon
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Molecular Beacon Probe Market Size Forecast by Applications
11.10.1 Nucleic Acid Detection and Analysis
11.10.2 Quantitative Detection of Heavy Metal Toxic Substances
11.10.3 Research On Tumor Markers
11.10.4 Research On Toxic Residual Antibiotics and Other Substances
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Molecular Beacon Probe Analysis and Forecast
12.1 Introduction
12.2 Latin America Molecular Beacon Probe Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Molecular Beacon Probe Market Size Forecast by Type
12.6.1 Tag Molecular Beacon
12.6.2 Label-free Molecular Beacon
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Molecular Beacon Probe Market Size Forecast by Applications
12.10.1 Nucleic Acid Detection and Analysis
12.10.2 Quantitative Detection of Heavy Metal Toxic Substances
12.10.3 Research On Tumor Markers
12.10.4 Research On Toxic Residual Antibiotics and Other Substances
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Molecular Beacon Probe Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Molecular Beacon Probe Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Molecular Beacon Probe Market Size Forecast by Type
13.6.1 Tag Molecular Beacon
13.6.2 Label-free Molecular Beacon
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Molecular Beacon Probe Market Size Forecast by Applications
13.10.1 Nucleic Acid Detection and Analysis
13.10.2 Quantitative Detection of Heavy Metal Toxic Substances
13.10.3 Research On Tumor Markers
13.10.4 Research On Toxic Residual Antibiotics and Other Substances
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Molecular Beacon Probe Market: Competitive Dashboard
14.2 Global Molecular Beacon Probe Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biocat
14.3.2 Bionano Genome
14.3.3 ThermoFisher
14.3.4 Biolegio
14.3.5 QIAGEN
14.3.6 Seattle Genetics
14.3.7 Karuna Therapeutics
14.3.8 Bristol-Myers Squibb
14.3.9 Pfizer
14.3.10 Oncolytics Biotech
14.3.11 Roche
